2^nd Euro Oncology Summit October 21-22, 2019 Prague | Czech Republic

We invite all the oncologists and the cancer researchers across the globe to attend the much awaited 2nd Euro Oncology Summit (Euro Oncology 2019) scheduled on October 21- 22, 2019 at Prague, Czech Republic which is the part of our Oncology Series Conferences.

The 2nd Euro Oncology Summit aims to brings together the Oncology Researchers, Oncologists, Oncology Surgeons, Surgical Oncologists, Radiologists, Oncology Pathologists, Pathologists, Immune Oncology Therapist, Nurses, health workers,  Multidisciplinary Oncology Specialists or Oncologists working in the area of various Organ Specific Cancers like: Breast Cancer, Colorectal Cancer, Colon Cancer, Brain tumours, blood cancers, urological cancer specialists, lung cancer specialists etc. The Cancer Experts to be gather here are basically from industry, hospitals, cancer centres and academia with the aim to discuss the current issues, trends including future innovations and strategies in the broad arena of Cancer research.

Our Europe Oncology Series Conferences comprise of Plenary sessions, Keynote sessions, Oncology expert meetings, Oral presentations, Poster Presentations, industrial presentations, One to one meetings, B2B Meetings, Panel discussions, round table meetings, Young Researcher Forums (YRF), International workshops, Exhibitor Presentations, Sponsor interactions, International Symposiums, Young Scientist awards etc. The Euro Oncology Summit comes up with Young Researcher/ Young Scientist awards to felicitate the young researchers and research scholars in an international platform and to flourish the young minds.

The scope of conference covers all fields of cancers. The sessions are designed in such a way that, it will cover the current trends and challenges in the Diagnosis, treatment and management of all cancer types, but not limited to: Acute Lymphoblastic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML), Adrenocortical Carcinoma, Anal Cancer, Basal and Squamous Cell Skin Cancer, Bile Duct Cancer, Bladder Cancer, Bone Cancer, Brain and Spinal Cord Tumors, Breast Cancer, Castleman Disease, Cervical Cancer, Chronic Lymphocytic Leukaemia (CLL), Chronic Myeloid Leukaemia (CML), Chronic Myelomonocytic Leukaemia (CMML), Colorectal Cancer, Ductal Carcinoma In Situ (DCIS), Endometrial Cancer, Oesophagus Cancer, Ewing Family of Tumors, Eye Cancer, Fallopian Tube Cancer, Fibrous Histiocytoma of Bone, Malignant, and Osteosarcoma, Gallbladder Cancer Gastrointestinal Carcinoid Tumors, Gastrointestinal Stromal Tumor (GIST),  Hodgkin Lymphoma, Head and Neck Cancer, Hepatocellular (Liver) Cancer, Histiocytosis, Langerhans Cell, Hypo pharyngeal Cancer, Intraocular Melanoma, Islet Cell Tumors, Pancreatic Neuroendocrine Tumors, Kaposi Sarcoma, Laryngeal and Hypo pharyngeal Cancer,  Leukaemia, Liver Cancer, Lung Cancer, Lung Carcinoid Tumor, Lymphoma, Lymphoma of the Skin, Melanoma Skin Cancer, Merkel Cell Skin Cancer, Multiple Myeloma, Myelodysplastic Syndromes, Nasal Cavity and Paranasal Sinuses Cancer Nasopharyngeal Cancer, Neuroblastoma, Non-Hodgkin Lymphoma, Lung Cancer, Oral Cavity and Oropharyngeal Cancer, Osteosarcoma, Ovarian Cancer, Pancreatic Cancer, Penile Cancer, Pituitary Tumors, Prostate Cancer, Plasma Cell Neoplasm/Multiple Myeloma, Pheochromocytoma, Paranasal Sinus and Nasal Cavity Cancer, Pancreatic Neuroendocrine Tumors (Islet Cell Tumors), Rectal Cancer, Renal Cell (Kidney) Cancer, Retinoblastoma, etc.